v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
  Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period (in shares) at Feb. 03, 2018     495,913        
Balance at beginning of period at Feb. 03, 2018 $ 4,141,413 $ 34,218 $ 991 $ 2,733,292 $ (2,322) $ 1,409,452 $ 34,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of ordinary shares in connection with equity incentive plans (in shares)     14,164        
Issuance of ordinary shares in connection with equity incentive plans 101,169   $ 29 101,140      
Tax withholdings related to net share settlement of restricted stock units (54,934)     (54,934)      
Share-based compensation 184,956     184,956      
Common stock issued to Cavium common stockholders (in shares)     153,376        
Common stock issued to Cavium common stockholders 3,273,053   $ 307 3,272,746      
Stock consideration for Cavium accelerated awards (in shares)     1,102        
Stock consideration for Cavium accelerated awards 7,804   $ 2 7,802      
Equity related issuance cost (2,927)     (2,927)      
Replacement equity awards attributable to pre-acquisition service $ 50,485     50,485      
Repurchase of common stock (in shares) (6,041)   (6,041)        
Repurchase of common stock $ (103,974)   $ (12) (103,962)      
Cash dividends declared and paid (cumulatively $0.24 per share) (148,081)         (148,081)  
Net income (loss) (179,094)         (179,094)  
Other Comprehensive income (loss) 2,322       2,322    
Balance at end of period (in shares) at Feb. 02, 2019     658,514        
Balance at end of period at Feb. 02, 2019 7,306,410   $ 1,317 6,188,598 0 1,116,495  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of ordinary shares in connection with equity incentive plans (in shares)     19,453        
Issuance of ordinary shares in connection with equity incentive plans 147,053   $ 40 147,013      
Tax withholdings related to net share settlement of restricted stock units (98,293)     (98,293)      
Share-based compensation 243,937     243,937      
Issuance of warrant for common stock 3,407     3,407      
Replacement equity awards attributable to pre-acquisition service $ 15,520     15,520      
Repurchase of common stock (in shares) (14,486)   (14,486)        
Repurchase of common stock $ (364,272)   $ (29) (364,243)      
Cash dividends declared and paid (cumulatively $0.24 per share) (159,573)         (159,573)  
Net income (loss) 1,584,391         1,584,391  
Other Comprehensive income (loss) 0            
Balance at end of period (in shares) at Feb. 01, 2020     663,481        
Balance at end of period at Feb. 01, 2020 8,678,580   $ 1,328 6,135,939 0 2,541,313  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of ordinary shares in connection with equity incentive plans (in shares)     13,172        
Issuance of ordinary shares in connection with equity incentive plans 86,673   $ 25 86,648      
Tax withholdings related to net share settlement of restricted stock units (108,089)     (108,089)      
Share-based compensation $ 241,714     241,714      
Repurchase of common stock (in shares) (1,251)   (1,251)        
Repurchase of common stock $ (25,202)   $ (3) (25,199)      
Cash dividends declared and paid (cumulatively $0.24 per share) (160,574)         (160,574)  
Net income (loss) (277,298)         (277,298)  
Other Comprehensive income (loss) 0            
Balance at end of period (in shares) at Jan. 30, 2021     675,402        
Balance at end of period at Jan. 30, 2021 $ 8,435,804   $ 1,350 $ 6,331,013 $ 0 $ 2,103,441